Our safety and pharma-covigilance experts ensure that a patient’s safety is paramount.
Pharma’s emphasis on employing strict safety reporting guidelines from the design stage of a trial ensures the quality and efficiency of our services and the safety of patients who participate in our trials.
Our safety and pharmacovigilance experts ensure that a patient’s safety is paramount. Critical to the success of any clinical trial is the early identification and management of adverse events.
Pharsh Pharma has a dedicated safety group employed at all stages of a trial to identify and coordinate the management of adverse events.
Our experienced safety and pharmacovigilance team provides:
- Full safety service requirements including safety database
- Tailored solutions for commercial and academic research across all phases
- A thorough understanding of safety reporting requirements across trial countries